Longitude Capital Partners III, LLC

Longitude Capital Partners III, LLC's trades of Inozyme Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-21 2022-04-19
B Purchase
1,355,000 +48.1%
3.69
USD 4,999,950 		1,355,000 +48.1% 3.69 USD 4,999,950
2022-02-02 2022-02-02
B Purchase
175,000 +inf%
27.00
USD 4,725,000 		175,000 +inf% 27.00 USD 4,725,000
2021-05-11 2021-05-11
B Purchase
235,000 +7.9%
17.00
USD 3,995,000 		235,000 +7.9% 17.00 USD 3,995,000
2020-09-01 2020-08-28
S Sale
1,049 -100.0%
10.75
USD 11,273 		1,049 -100.0% 10.75 USD 11,273
2020-09-01 2020-08-28
S Sale
2,447 -100.0%
10.75
USD 26,296 		2,447 -100.0% 10.75 USD 26,296
2020-07-28 2020-07-28
B Purchase
625,000 +28.5%
16.00
USD 10,000,000 		625,000 +28.5% 16.00 USD 10,000,000
2020-07-14 2020-07-10
US 89Bio Inc (ETNB)
B Purchase
109,090 +4.4%
27.50
USD 2,999,975 		109,090 +4.4% 27.50 USD 2,999,975
2019-11-27 2019-11-25
B Purchase
937,000 +28.7%
8.00
USD 7,496,000 		937,000 +28.7% 8.00 USD 7,496,000
// ... existing code ... // ... rest of the file ...